Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery

Novel CRISPR solution leverages Eclipse™ Platform to enable a faster path to therapeutic development

Aug 02, REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional screening assays. The innovative solution leverages Synthego’s Eclipse™ Platform. This high-throughput cell engineering platform delivers cell-based models for disease research by providing highly predictable CRISPR-engineered cells at scale through the integration of engineering, bioinformatics, and proprietary science. Synthego’s Engineered Cell Libraries provide unparalleled speed, scalability, and efficiency to accelerate the drug discovery process by enabling a faster path between experimental design and execution. More>>

Datwyler to Double Capacity at its Indian Facility

Datwyler is increasing capacity for all three of its production standards in Pune, India. The expansion will nearly double capacity and add 400 jobs. More>>

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

HEIDELBERG, Germany, August 1, 2022 / B3C newswire / -- BioMed X, a German independent research institute, announces the start of its new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with Healthcare Business of Merck KGaA, Darmstadt, Germany. The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function. More>>

Can Packaging Serialisation Be As Simple As 1,2,3?

For businesses that operate in the pharmaceutical and health categories, traceability, safety, and security are top priorities when designing packaging. More>>

Gerresheimer Awarded EcoVadis Gold for Sustainable Corporate Management for the First Time

More>>

DSV and Ørsted to Test Cargo Drones at Anholt Offshore Wind Farm

DSV, the global Danish transport and logistics company, and Ørsted, the world-leading Danish energy company, will test long-distance drone transport of spare parts and tools in the Kattegat Sea in Denmark. More>>

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Expands bioanalytical services to include many emerging areas worldwide. More>>

Datwyler Launches 5/8-Inch Rigid Needle Shield, Infusion Discs

New solutions expand the company’s portfolio of elastomer components to meet growing and changing patient needs

Altdorf, Switzerland, 11 July 2022— Datwyler, a leading manufacturer of elastomer components for pharmaceutical packaging, is expanding its portfolio with two new products to meet evolving patient demands. The new offerings include a 5/8 in. rigid needle shield (RNS) to address the rising need for prefilled syringes to contain vaccines for intramuscular injection, and isoprene rubber discs for infusion therapies. More>>

Signant Strengthens Digitally Optimized Trial Strategy with Delivery of Study Supplies Direct to Patients’ Homes

Signant Health, the leader in evidence generation for modern clinical trials, announced today enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution. More>>

Connect in Pharma Launches Art Exhibition and Charity Partnership to Raise Funds for Rare Disease Research

Geneva-based event pledges five Swiss francs per visitor to support new drug development project. More>>